new oral glp 1 agonist Not an April fool's prank! The small molecule GLP-1 receptor agonist, orforglipron, has been approved by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode A new class of oral

If Glutathione is taken by people suffering from asthma, it can lead to wheezing

The former approach is suitable for acute oxidative stress-induced injury, where rapid ROS elimination blocks pathological progression, whereas the latter applies to chronic or recovery phases, where ROS homeostasis supports physiological function and promotes tissue regeneration

Taken together, the prevention of oxidative stress and inflammation is a key mechanism for the renoprotective effects of GLP-1RAs

SCAP: SREBP cleavage-activating protein

Kotla S, Imanishi M, Zhang A, Ko KA, Samanthapudi V, Savage H, et al

Finally, a yellow powder was obtained